Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-306

4 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 16729-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Azacitidine Structural Formula (Azacitidine For Inj Structure)

Azacitidine Structural Formula (Azacitidine For Inj Structure)
Chemical structure of azacitidine, the active ingredient in the product Azacitidine injection, powder, lyophilized, for solution by Accord Healthcare Inc.*
FDA Label Image

Kaplan-meier Curve Of Time To Death From Any Cause: (intent-to-treat Population) (Azacitidine For Inj Plot)

Kaplan-meier Curve Of Time To Death From Any Cause:  (intent-to-treat Population) (Azacitidine For Inj Plot)
A Kaplan-Meier survival curve chart comparing the proportion surviving over time (months from randomization) between two groups labeled AZA (Azacitidine) and CCR. The chart includes a log-rank p-value, hazard ratio with confidence interval, death counts, and a risk table showing numbers at risk for both groups over time.*
FDA Label Image

Principal Display Panel (100 mg azacitidine-for-inj-label)

Principal Display Panel (100 mg azacitidine-for-inj-label)
Azacitidine for Injection 100 mg lyophilized powder vial label. The vial is for subcutaneous and intravenous use only. The label includes storage instructions for unconstituted vials, manufacturer information for Accord Healthcare Inc. and Intas Pharmaceuticals Limited, and caution that the product is a cytotoxic agent. The label also features barcodes and areas reserved for lot and expiration information.*
FDA Label Image

Principal Display Panel (100 mg azacitidine-for-inj-carton)

Principal Display Panel (100 mg azacitidine-for-inj-carton)
Packaging label for Azacitidine 100 mg injection, lyophilized powder for solution by Accord Healthcare Inc. The label includes dosage form instructions for subcutaneous and intravenous use only, a caution for cytotoxic agent, and storage information. The label shows the NDC number 16729-306-10, manufacturing details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.